Atlas Trials

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia

Clinical trial NCT06067425 · TERMINATED

Trial details

NCT number
NCT06067425
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Osteochondrodysplasia
Start date
2023-10-10
Primary completion
2025-02-12
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.